2 acute toxicity studies Flashcards
what are in vivo toxicity studies and what is the point of them?
-scientific study of adverse effects that occur in animals due to a chemical substance (how strong is effect, is it debilitating, etc)
-to observe and report symptoms, mechanisms, detection and treatment of toxic substances
how long should we wait to see toxicological effects?
what are single dose/acute toxicity studies? what is the point of them?
-administration of a single dose or multiple doses (more rare) within 24 hours
-different doses in different animals, and effect is observed for 14 days
-to acquire data on the dose-effect relationship of a new drug
-regulatory body requires the acute toxicity test report for labelling and classification of substances for human use
-goal is to find LD50
what are the main goals for single dose studies?
-to determine LD50 during short-term exposure
-to investigate the potential for acute toxicity in humans
-provides insight into target organs and toxic mode of action (toxicokinetics)
-provide data on signs expected in cases of acute overdose (extrapolate warning signs from animals)
-time course of drug-induced clinical observations (hourly time course)
-to establish dose levels for subsequent repeated-dose studies (no effect to death)
-species differences in toxicity (usually use rodents)
what are the initial considerations before testing (on animals)?
-identify the chemical structure of the test substance
-physio-chemical properties (solubility) (if IV, needs to be soluble in saline and water)
-results in any other in vitro and/or in vivo toxicity tests on the substance
-toxicological data in structurally related substances or similar mixtures
what are the two tests in acute oral toxicity?
-limit test
-main test
-to save number of animals
-not the only acute toxicity study; just more drugs are taken orally
what is the limit test?
-dose one animal at the test dose (at 2000mg/kg or 5000 mg/kg)
-if animal dies, conduct the main test to determine the LD50
-if the animal survives, dose four additional animals sequentially so that a total of five animals are tested
when is the LD50 greater than the test dose? (in the limit test)
-the LD50 is greater than the test dose (2000 mg/kg) when three or more animals survive
when is the LD50 lesser than the test dose? (limit test)
-the LD50 is less than the test dose (2000 mg/kg) when three or more animals die
what is the main test?
-single animals are dosed in sequence usually at 48hr intervals
-starting dose is selected based on previous data (if available)
-the first animal is dosed a step below the best preliminary estimate of the LD50
-if the animal survives, the second animal receives a higher dose
-if the first animal dies or appears moribund (severly debilitating), the second animal receives a lower dose
what is the dose progression factor?
the dose progression factor should be chosen to be the antilog of: 1/(the estimated slope of the dose-response curve)
-factor is to see how much increase the dose is for testing
what is the default of the dose progression factor?
-dose progression should remain constant throughout testing
-when there is no information on the slope of the substance to be tested, a dose progression factor of 3.2 is used (corresponds to a slope of 2)
-using the default progression factor, doses would be selected from the sequence 1.75 (very toxic), 5.5, 17.5, 55, 175, 550, 2000mg/kg
what is the reversal process?
a combination of stopping criteria is used to keep the number of animals low (6-15 animals)
-at least four animals have followed the first reversal (when the response changes from one outcome to another)
what is the stopping criteria to ensure the number of animals low (6-15 animals)?
-3 consecutive animals survive at the upper bound (highest concentration, usually 2000 mg/kg or 5000 mg/kg-low toxicity compounds)
-at least four animals have followed the first reversal
-five reversal occur in any six consecutive animals tested (e.g. OXOXOX)
what are done with the moribund animals?
moribund animals killed for humane reasons are considered in the same way as animals that died on test
-if an animal unexpectedly dies late in the study, stop dosing and observe all animals to see if they also die during a similar observation period
-if the above is true, it is appropriate to start the study again beginning at least two steps below the lowest dose with deaths (and increasing the observation period)